tiprankstipranks
Trending News
More News >
Xilio Therapeutics Inc (XLO)
NASDAQ:XLO
US Market

Xilio Therapeutics (XLO) Ownership - Who Owns Xilio Therapeutics?

Compare
212 Followers

Xilio Therapeutics (XLO) Ownership Overview

18.01%2.78%33.70%2.08%43.42%
18.01% Insiders
33.70% Other Institutional Investors
2.08% ETFs
43.42% Public Companies and
Individual Investors
The ownership structure of Xilio Therapeutics (XLO) stock is a mix of institutional, retail, and individual investors. Approximately 38.56% of the company’s stock is owned by Institutional Investors, 18.01% is owned by Insiders, and 43.42% is owned by Public Companies and Individual Investors.
The ownership structure of Xilio Therapeutics (XLO) stock is a mix of institutional, retail, and individual investors. Approximately 36.48% of the company’s stock is owned by Institutional Investors, 18.01% is owned by Insiders, and 2.08% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 18, 2025
xxxxxxxxxxxxx
$24677
Jun 18, 2025
xxxxxxxxxxxxx
$47600

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
9,105,451Insider17.34%6,200,812
1,091,570Institution2.08%743,359
1,091,570Institution2.08%743,359
313,181Institution0.60%213,276
281,172Insider0.54%191,478
70,000Insider0.13%47,670
56,081Institution0.11%38,191
1,107Institution<0.01%754

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,091,570Institution2.08%743,359
313,181Institution0.60%213,276
56,081Institution0.11%38,191
1,107Institution<0.01%754

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
723,745Institution1.38%576,608
367,825Institution0.70%293,046

FAQ

Who Owns Xilio Therapeutics Inc (XLO)?
According to the latest TipRanks data, approximately 33.70% of the company's stock is held by institutional investors, 18.01% is held by insiders, and 43.42% is held by retail investors.
    What percentage of Xilio Therapeutics Inc (XLO) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 33.70% of Xilio Therapeutics Inc (XLO) stock is held by institutional investors.
      What percentage of Xilio Therapeutics Inc (XLO) stock is held by retail investors?
      According to the latest TipRanks data, approximately 43.42% of Xilio Therapeutics Inc (XLO) stock is held by retail investors.
        Who owns the most shares of Xilio Therapeutics Inc (XLO)?
        Gilead Sciences Inc owns the most shares of Xilio Therapeutics Inc (XLO).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.